title: Emotion recognition and oxytocin in patients with schizophrenia.
abstract: BACKGROUND
  Studies have suggested that patients with schizophrenia are impaired at recognizing emotions. Recently, it has been shown that the neuropeptide oxytocin can have beneficial effects on social behaviors.
  
  
  METHODS
  To examine emotion recognition deficits in patients and see whether oxytocin could improve these deficits, we carried out two experiments. In the first experiment we recruited 30 patients with schizophrenia and 29 age- and IQ-matched control subjects, and gave them an emotion recognition task. Following this, we carried out a second experiment in which we recruited 21 patients with schizophrenia for a double-blind, placebo-controlled cross-over study of the effects of oxytocin on the same emotion recognition task.
  
  
  RESULTS
  In the first experiment we found that patients with schizophrenia had a deficit relative to controls in recognizing emotions. In the second experiment we found that administration of oxytocin improved the ability of patients to recognize emotions. The improvement was consistent and occurred for most emotions, and was present whether patients were identifying morphed or non-morphed faces.
  
  
  CONCLUSIONS
  These data add to a growing literature showing beneficial effects of oxytocin on social-behavioral tasks, as well as clinical symptoms.
authors.affiliation: Laboratory of Neuropsychology, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.
authors.forename: B B
authors.initials: BB
authors.lastname: Averbeck
authors.affiliation: King's College London, Institute of Psychiatry, Cognition, Schizophrenia and Imaging Laboratory, Department of Psychosis Studies, London, UK.
authors.forename: T
authors.initials: T
authors.lastname: Bobin
authors.affiliation: Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, UCL, London, UK.
authors.forename: S
authors.initials: S
authors.lastname: Evans
authors.affiliation: King's College London, Institute of Psychiatry, Cognition, Schizophrenia and Imaging Laboratory, Department of Psychosis Studies, London, UK.
authors.forename: S S
authors.initials: SS
authors.lastname: Shergill
mesh_terms: D000328:Adult; D018592:Cross-Over Studies; D004311:Double-Blind Method; D004644:Emotions / Q000187:drug effects* / Q000502:physiology; D005149:Facial Expression; D005260:Female; D006801:Humans; D008297:Male; D010121:Oxytocin / Q000008:administration & dosage / Q000494:pharmacology*; D011897:Random Allocation; D021641:Recognition, Psychology / Q000187:drug effects* / Q000502:physiology; D012559:Schizophrenia / Q000188:drug therapy* / Q000503:physiopathology; D012938:Social Perception
chemical_list: D010121:Oxytocin